Positive Preclinical Data for NKTR-214, an Investigational Cancer …

Positive Preclinical Data for NKTR-214, an Investigational Cancer …

Filed under: drug abuse treatment outcome study

In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for naloxegol (NKTR-118), an investigational drug candidate, which has completed Phase 3 clinical development as a once- daily, oral tablet for the treatment of …
Read more on Sacramento Bee

Why Zohydro May Or May Not Be Approved

Filed under: drug abuse treatment outcome study

Zogenix's first product, Sumavel DosePro, is a drug and device combo that uses the drug sumatriptan to treat migraines. It was approved in … While the panel members voiced major concerns over the abuse potential with Zohydro, he pointed out that …
Read more on Seeking Alpha

Multidimensional Family Therapy, An Introduction (Part 1 of 2) – An overview of the Multidimensional Family Therapy model, presented by its creator, Howard Liddle. This is part 1 of 2. To see additional videos, including p…